- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Distinguishing Sedation From Efficacy In Antipsychotic Treatment
A Virtual Live Event for PsychU members in Florida.
This presentation will highlight the importance of distinguishing sedation from antipsychotic treatment efficacy. Symptomatology of acute agitation, neurobiological mechanisms for sedation, and potential consequences of long-term sedation will be discussed to review pharmacologic considerations when selecting an antipsychotic.
Featuring
-
Jacquelyn Canning, PharmD, BCPP (OPDC)
Clinical & Scientific Liaison
-
Aneta Fornal, PharmD (OPDC)
Medical Science Liaison
Speakers are paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
Register
This event registration is closed.